Administrative Core
行政核心
基本信息
- 批准号:10704708
- 负责人:
- 金额:$ 24.74万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-14 至 2027-07-31
- 项目状态:未结题
- 来源:
- 关键词:AccountingAnimal ExperimentationAnimalsCancer CenterClinicClinicalClinical ManagementClinical TrialsCollaborationsCombined Modality TherapyCommunicationComprehensive Cancer CenterCore FacilityDataDevelopment PlansDocumentationEducationEnrollmentEnsureFeedbackFloridaFundingGenomicsGoalsGrantHumanHuman ResourcesHuman Subject ResearchIndividualInstitutionInvestigationLaboratoriesLeadershipManuscriptsMonitorMulti-Institutional Clinical TrialMulticenter TrialsNational Cancer InstituteOffice of Administrative ManagementOralPerformancePreparationProgress ReportsRadiationResearchResearch PersonnelResourcesScheduleServicesSiteStudy SubjectSystemTimeTrainingTreatment EfficacyUniversitiesWorkWritingexperiencehuman subjectinnovationmeetingsoperationprograms
项目摘要
PROJECT SUMMARY
Administrative Core
The Administrative Core is responsible for the overall leadership, management, and execution of the
ROBIN center, and it will provide overall organizational, administrative, scientific and clinical management. The
Administrative Core will oversee and coordinate all ROBIN program components and centrally monitor and
evaluate their performance. In addition, the Administrative Core will facilitate all interactions with the External
Advisory Board (EAB), the Steering Committee, and the other sites of the national ROBIN program. This
ROBIN center involves 3 institutions (Cleveland Clinic, Emory University, and Case Western Reserve
University), with multiple enrollment sites (Cleveland Clinic system, Cleveland Clinic Florida system, Emory
University system) across 2 NCI-designated Comprehensive Cancer Centers (Case Comprehensive Cancer
Center, Emory Cancer Center), with representation across these institutions as project and core leaders. The
Administrative Core personnel will be led by Drs. Chan, Yu, and Scott, with collaboration from the trial and
project leads. Both Drs. Chan and Yu (ROBIN PIs) have extensive experience in managing multi-institution
clinical trial and laboratory-based research programs. The specific aims for the Administrative Core are as
follows. In Aim 1, the Core will provide all organizational, administrative, educational, and scientific
coordination for the ROBIN center projects and cores by cultivating and promoting the ROBIN team through
innovation and excellence, collaboration, leveraging resources, and providing constructive feedback.
In Aim 2, the Core will provide centralized administrative management for all fiscal aspects of the ROBIN
center, including but not limited to clinical trial execution, accounting of grant funds, progress reports,
communication, meeting scheduling and minutes, and manuscript and grant preparation. In Aim 3, the Core
will evaluate research progress through oral and written documentation, with regular input from the EAB,
Steering Committee, and National Cancer Institute (NCI) leadership to ensure that each project meets its
objectives within the proposed time frame and to facilitate interactions with other ROBIN sites for trans-ROBIN
center projects. In Aim 4, the Core will ensure integration across ROBIN components, including projects and
cores, across all sites, and provide interaction through scientific exchanges, coordination of an annual scientific
retreat, and through training and development plans that will ensure state-of-the-art practices. In Aim 5, the
Core will ensure and monitor best practices for human subjects and animal research for all ROBIN center
projects and cores as well as clinical and data operations, and to ensure adequate human and animal
biospecimens for all projects (with the Translational and Clinical Correlates Core).
项目摘要
行政核心
行政核心负责全面领导、管理和执行
ROBIN中心,它将提供全面的组织,行政,科学和临床管理。的
管理核心将监督和协调所有ROBIN计划组成部分,并集中监控和
评估他们的表现。此外,行政核心将促进与外部的所有互动,
咨询委员会(EAB),指导委员会,和国家罗宾计划的其他网站。这
ROBIN中心涉及3个机构(克利夫兰诊所、埃默里大学和凯斯西储
大学),有多个入组中心(克利夫兰诊所系统、克利夫兰诊所佛罗里达系统、埃默里
大学系统)在2个NCI指定的综合癌症中心(病例综合癌症中心)
中心,埃默里癌症中心),在这些机构的代表作为项目和核心领导人。的
管理核心人员将由Chan、Yu和Scott博士领导,并与试验和
项目领导。陈博士和余博士(ROBIN PIs)在管理多所机构方面拥有丰富的经验
临床试验和实验室研究项目。行政核心的具体目标是:
如下在目标1中,核心将提供所有组织、行政、教育和科学
通过培养和提升ROBIN团队,协调ROBIN中心项目和核心,
创新和卓越,协作,利用资源,并提供建设性的反馈。
在目标2中,核心将为ROBIN的所有财务方面提供集中的行政管理
中心,包括但不限于临床试验的执行,补助资金的核算,进度报告,
沟通,会议安排和会议记录,手稿和赠款准备。Aim 3核心
将通过口头和书面文件评估研究进展,并定期从EAB输入,
指导委员会和国家癌症研究所(NCI)的领导,以确保每个项目符合其
在建议的时间框架内实现目标,并促进与其他ROBIN站点的交互,以实现跨ROBIN
中心项目。在目标4中,核心将确保跨ROBIN组件的集成,包括项目和
核心,并通过科学交流提供互动,协调年度科学
培训和发展计划将确保采用最先进的做法。在目标5中,
核心将确保和监测所有ROBIN中心的人类受试者和动物研究的最佳实践
项目和核心以及临床和数据操作,并确保足够的人和动物
所有项目的生物标本(具有转化和临床相关核心)。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Timothy An-thy Chan其他文献
Timothy An-thy Chan的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Timothy An-thy Chan', 18)}}的其他基金
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
基因组和微环境决定因素、时间动态以及基于放射的联合疗法的治疗效果
- 批准号:
10746700 - 财政年份:2023
- 资助金额:
$ 24.74万 - 项目类别:
Project 3 Molecular Mechanisms Underlying Therapy Response to Radiation and Immune Checkpoint Blockade
项目 3 辐射和免疫检查点封锁治疗反应的分子机制
- 批准号:
10818969 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
基因组和微环境决定因素、时间动态以及基于放射的联合疗法的治疗效果
- 批准号:
10875876 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
基因组和微环境决定因素、时间动态以及基于放射的联合疗法的治疗效果
- 批准号:
10704661 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Genomic and Microenvironmental Determinants, Temporal Dynamics, and Treatment Efficacy of Radiation-Based Combination Therapies
基因组和微环境决定因素、时间动态以及基于放射的联合疗法的治疗效果
- 批准号:
10526300 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Project 1 Genetic and Immunologic Mechanisms Underlying Combination Sacituzumab plus Radiation Therapy for Bladder Cancer
项目 1 Sacituzumab 联合放射治疗膀胱癌的遗传和免疫机制
- 批准号:
10704713 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
Project 1 Genetic and Immunologic Mechanisms Underlying Combination Sacituzumab plus Radiation Therapy for Bladder Cancer
项目 1 Sacituzumab 联合放射治疗膀胱癌的遗传和免疫机制
- 批准号:
10526303 - 财政年份:2022
- 资助金额:
$ 24.74万 - 项目类别:
相似海外基金
Development of a Drosophila-based platform to replace and reduce animal experimentation in epilepsy research
开发基于果蝇的平台来取代和减少癫痫研究中的动物实验
- 批准号:
NC/V001051/1 - 财政年份:2020
- 资助金额:
$ 24.74万 - 项目类别:
Research Grant
Doctoral Dissertation Research: Ethical Issues in Animal Experimentation
博士论文研究:动物实验的伦理问题
- 批准号:
1424484 - 财政年份:2014
- 资助金额:
$ 24.74万 - 项目类别:
Standard Grant
Tissue formation involving stem/progenitor cell research and animal experimentation (N01)
涉及干/祖细胞研究和动物实验的组织形成(N01)
- 批准号:
30245585 - 财政年份:2006
- 资助金额:
$ 24.74万 - 项目类别:
Collaborative Research Centres
Animal experimentation and cardiac phenotyping of transgenic mouse models
转基因小鼠模型的动物实验和心脏表型分析
- 批准号:
13327687 - 财政年份:2005
- 资助金额:
$ 24.74万 - 项目类别:
Research Units
Animal Experimentation system as an infrastructure to support translational progression of diabetes research to medical practice
动物实验系统作为支持糖尿病研究向医学实践转化的基础设施
- 批准号:
17200029 - 财政年份:2005
- 资助金额:
$ 24.74万 - 项目类别:
Grant-in-Aid for Scientific Research (A)














{{item.name}}会员




